MASOLA, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 1.193
EU - Europa 1.155
AS - Asia 475
SA - Sud America 5
OC - Oceania 2
Totale 2.830
Nazione #
US - Stati Uniti d'America 1.190
GB - Regno Unito 391
CN - Cina 274
IT - Italia 165
SG - Singapore 135
SE - Svezia 122
FR - Francia 106
RU - Federazione Russa 97
IE - Irlanda 86
FI - Finlandia 75
DE - Germania 57
VN - Vietnam 37
UA - Ucraina 22
BE - Belgio 13
AT - Austria 8
ID - Indonesia 8
IL - Israele 6
IN - India 5
RO - Romania 4
CH - Svizzera 3
CL - Cile 3
CA - Canada 2
DK - Danimarca 2
KG - Kirghizistan 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
HK - Hong Kong 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.830
Città #
Southend 355
Chandler 271
Jacksonville 136
Woodbridge 130
Singapore 109
Ann Arbor 96
Dublin 84
Beijing 60
Houston 46
Ashburn 43
Wilmington 39
Lawrence 37
Princeton 37
Nanjing 21
Dong Ket 20
New York 20
Shenyang 20
Jinan 19
Helsinki 18
Redmond 17
Verona 17
Los Angeles 14
Brussels 13
Hebei 10
Milan 10
Seattle 10
Boardman 9
Taizhou 9
Tianjin 9
Jakarta 8
Jiaxing 8
Ningbo 8
Vienna 8
Nanchang 7
Padova 7
Chicago 6
Guangzhou 6
Rome 6
Zhengzhou 6
Fairfield 5
Hangzhou 5
Sindelfingen 5
Auburn Hills 4
Catanzaro 4
Genova 4
Kochi 4
Lancaster 4
Moscow 4
Norwalk 4
Changsha 3
Detroit 3
Florence 3
Fuzhou 3
Haikou 3
Kent 3
Novokuznetsk 3
Redwood City 3
San Francisco 3
Santa Clara 3
Taiyuan 3
Tel Aviv 3
Bishkek 2
Cambridge 2
Dearborn 2
Dongguan 2
Foggia 2
Las Vegas 2
Manfredonia 2
Messina 2
Oxford 2
Parma 2
Phoenix 2
Pomezia 2
Shanghai 2
Tappahannock 2
Venice 2
Almaty 1
Auckland 1
Augusta 1
Aversa 1
Baku 1
Bangalore 1
Bari 1
Bergamo 1
Bologna 1
Bolzano 1
Borgo Valsugana 1
Bratislava 1
Canberra 1
Casalgrande 1
Chengdu 1
Clearwater 1
Colombo 1
Cremona 1
Crespellano 1
Crotone 1
Dallas 1
Düsseldorf 1
Eden Prairie 1
Edinburgh 1
Totale 1.882
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 171
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 170
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 107
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 107
mTOR inhibitors and renal allograft: Yin and Yang. 106
Sulodexide and glycosaminoglycans in the progression of renal disease. 102
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 98
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 97
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 94
Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats. 93
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 92
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 89
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 85
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 79
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 78
L: -citrulline Prevents Alveolar and Vascular Derangement in a Rat Model of Moderate Hyperoxia-induced Lung Injury. 77
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 77
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 75
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 75
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 75
Heparanase as a target in cancer therapy. 74
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 70
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 70
Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion 63
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 63
Heparanase: another renal player controlled by vitamin d. 62
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells. 60
LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase 60
Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells 60
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. 60
The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells 56
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. 55
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 54
Impact of heparanase on renal fibrosis. 52
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 52
Endothelial Glycocalyx as a Regulator of Fibrotic Processes 43
Role of Heparanase in Tumor Progression: Molecular Aspects and Therapeutic Options 26
Totale 2.927
Categoria #
all - tutte 9.843
article - articoli 9.399
book - libri 0
conference - conferenze 444
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020221 0 0 0 0 37 37 32 14 16 42 17 26
2020/2021297 23 74 5 26 37 26 11 9 5 3 33 45
2021/2022280 26 48 4 54 4 9 10 22 7 8 17 71
2022/2023673 51 92 65 103 64 137 15 39 80 4 16 7
2023/2024255 16 25 25 12 32 42 9 19 1 17 45 12
2024/2025268 45 43 30 131 19 0 0 0 0 0 0 0
Totale 2.927